PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHaemophilus infections
MeSH D006192 - haemophilus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016871:Pasteurellaceae infections
0 Companies
0 Drugs
Success rate
D006192: 
Haemophilus infections
140 Companies
64 Drugs
$
Success rate
D002602:Chancroid
92 Companies
16 Drugs
$
Success rate
D008583:Haemophilus meningitis
15 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganOfloxacin Ocuflox  1993-07-30   
Levofloxacin Levofloxacin  2011-02-10   
Rifampin Rifampin  2016-01-19   
Altaire PharmaceuticalsOfloxacin Ofloxacin  2013-04-29   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
43/43
Approved: 43Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Avibactam,
Ceftazidime
Alcon Research
Dexamethasone
Allergan
Ciprofloxacin,
Gatifloxacin,
Hydrocortisone,
Hydrocortisone butyrate,
Hydrocortisone probutate,
Levofloxacin,
Ofloxacin,
Prednisolone,
Prednisolone tebutate
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use